3[3]Guilhot F, Chastang C, Michallet M, et al. Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia[J]. N Eng J Med, 1997,337(4): 223-229.
4[4]Druker B J, Lydon NB. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia[J]. J Clin Invest, 2000, 105 (1): 3-7.
5[5]Travis LB, Pierre RV, Dewald GW. Ph-negative chronic granulocytic leukemia: a nonentity[J]. Am J Clin Pathol,1986, 85(2): 186-193.
6[6]Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia[J]. Semin Oncol, 1998, 25(1): 19-26.
7[7]Diedamm J, Michaux L, Criel A, et al. Genetic abnormalities in chronic lymphocytic leukemia and their clinical prognostic implication[J]. Cancer Genet Cytogenet, 1997,94(1): 27-35.
8[8]Jaffe ES, Harris NL, Stein H, et al. World Health Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M]. IARL Press: Lyon, 2001. 15-44.
10[10]Melnick A, Licht JD. Deconstructing a disease: RAR alpha, its fusion partners and their roles in the pathogenesis of acute promyelocytic leukemia[J]. Blood, 1999,93(10): 3167-3215.
7Linabery A M,Ross J A.Trends in childhood cancer incidence in the U.S.(1992-2004)[J].Cancer,2008,112(2):416-432.
8Deschler B,Labbert M.Acute myeloid leukemia:epidemioiogy and etiology[J].Cancer,2006,107(9):2099-2107.
9Downing J R,Shannon K M.Acute leukemia:a pediatric perspective[J].Cancer Cell,2002,2(6):437-445.
10Liang D C,Shih L Y,Yang C P,et al.Multiplex reverse transcription polymerase chain reaction assay for the detection of major fusion transcripts in Taiwan Residents children with B-lineage acute lymphoblastic leukemia[J].Med Pediatr Oncol,2002,9(1):12-17.
